-- Eversource Energy (ES) 週三表示，公司第一季所有主要業務部門的獲利均有所成長，其中天然氣業務成長最為顯著，增幅高達 35%。 該公司表示，業績成長主要得益於積極的基礎設施投資和大幅提高基準費率。 天然氣分銷業務的成長最為顯著，預計 2026 年第一季獲利將達到 2.953 億美元，高於去年同期的 2.184 億美元。 此次 35% 的成長主要歸功於 Eversource 所有天然氣業務於 2025 年 11 月 1 日生效的新基準分銷費率。 此次費率上調旨在彌補公司天然氣基礎設施持續投資的成本，但營運和維護成本的上升以及利息支出的增加略微抵消了部分收益。 電力傳輸業務部門也呈現穩定成長，獲利2.243億美元，高於2025年第一季的1.994億美元。 同樣，電力配送業務部門的獲利也達到2.028億美元，高於去年同期的1.884億美元。 管理層將這一增長歸功於其位於馬薩諸塞州和新罕布什爾州的公用事業公司基本配電費率的提高，這有助於抵消更高的房產稅和折舊成本。 儘管營收表現強勁，但Eversource指出，更高的利息支出對所有三個業務部門都產生了影響，這反映了公用事業行業普遍面臨的高利率環境。
Related Articles
Asia
Indian Equities End Flat on Thursday as Earnings Support Offsets Weakness
Indian benchmark indices ended largely unchanged on Thursday as gains driven by earnings-related buying offset broader market weakness.The BSE Sensex fell 114.00 points, or 0.2%, to close at 77,844.52, while the NSE Nifty 50 slipped 4.30 points, or 0.02%, to settle at 24,326.65.Expectations of easing tensions between the US and Iran further supported investor sentiment. Tehran is reportedly reviewing the latest U.S. proposals aimed at ending the conflict.In corporate developments, Bharat Forge (NSE:BHARATFORG, BOM:500493) reported a decline in consolidated profit in fiscal Q4 to 2.33 billion rupees from 2.83 billion rupees a year earlier. Revenue from operations, however, rose to 20.3 billion rupees from 17.0 billion rupees.Larsen & Toubro (NSE:LT, BOM:500510) gained after its buildings and factories business secured three large orders from a real estate client for projects across three states, according to a filing. The company classifies large orders in the range of 25 billion rupees to 50 billion rupees.
$^BSE$^NSEI$BOM:500493$BOM:500510$NSE:BHARATFORG$NSE:LT
Asia
Heilongjiang ZBD Pharmaceutical Wins Bids for Traditional Chinese Drug Program
Two of Heilongjiang ZBD Pharmaceutical's (SHA:603567) products won bids from China's procurement program for traditional medicines, according to a Thursday filing with the Shanghai bourse.The products include ZBD's quick-acting sugar syrup for children, indicated for fever and sore throat, and its Xiangdan injection for angina pectoris or chest pain, the filing said.
$SHA:603567
Research
BTIG Upgrades Fortinet to Buy From Neutral, Price Target is $125
Fortinet (FTNT) has an average rating of hold and mean price target of $102.03, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
$FTNT